gillem-tulloch
wisetech-global
celltrion-inc
byd-company-limited
poly-development
kangmei-pharmaceutical
geely-auto
iflytek
irb-infra
sichuan-road-bridge
advanced-micro-fabrication-equipment
pdd-holdings
gds-holdings
weichai-power
shanghai-putailai-new-energy-tech
ke-holdings
hangzhou-tigermed-consulting
kuaishou-technology
aier-eye-hospital
yuexiu-property
sensetime-group-inc
china-resources-beer
gotion-high-tech
kalyan-jewellers-india
posco-dx
zhongji-innolight-co-ltd
kuang-chi-technologies
supcon-technology
dentsu-group
zjld-group
arm-holdings
geovis-technology
hybe-co-ltd
china-national-software-and-service
china-rare-earth-resources-and-technology
zhangjiang-hi-tech-park-development
telix-pharmaceuticals
western-superconducting-technologies
Insights
1 December, 2023
NEWSLETTER: EVERGRANDE (3333 HK)
Never profitable

Fredrik Oeqvist
Evergrande’s much delayed and recently published 2021 annual report makes clear that it significantly overstated revenue and earnings – most likely for many years. Contrary to what some people think, Evergrande was not so much a victim of tightened liquidity or a COVID-induced property market downturn; its problems were far more fundamental – there were never any profits....
Read More
18 August, 2020
NEWSLETTER: COMING HOME?
Watch out for the privatisation “squeeze out”

Gillem Tulloch
The proposed Holding Foreign Companies Accountable Act could force hundreds of Chinese companies listed on US exchanges to delist over the next few years. For many large companies, seeking a secondary listing in Hong Kong or the mainland is a sensible insurance policy. However, investors should be wary of companies which decide to privatise and then relist. Our analysis of...
Read More